Literature DB >> 22958492

The renin-angiotensin-aldosterone system in podocytes.

Dirk Oliver Wennmann1, Hsiang-Hao Hsu, Hermann Pavenstädt.   

Abstract

The renin-angiotensin-aldosterone system (RAAS) plays a critical role in kidney function and its inhibition reduces proteinuria and preserves kidney function in patients with chronic kidney disease. Recent studies have shown that podocytes generate many components of the RAAS and they express receptors of RAAS, including angiotensin II, mineralocorticoid, and prorenin receptors. Crucial functions of podocytes, such as contraction, apoptosis, autophagocytosis, and cytoskeletal organization, have been shown to be regulated by the angiotensin II type 1 receptors. An activation of the glomerular RAAS and protection from podocyte injury by RAAS inhibitors have been shown in many glomerular diseases. Exploring the interaction between the local RAAS and the signaling involved in RAAS activation in podocytes will lead to new therapeutic strategies of podocyte protection.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22958492     DOI: 10.1016/j.semnephrol.2012.06.009

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  22 in total

1.  AT1R blockade in adverse milieus: role of SMRT and corepressor complexes.

Authors:  Tejinder Singh; Kamesh Ayasolla; Partab Rai; Nirupama Chandel; Shabirul Haque; Rivka Lederman; Mohammad Husain; Vasupradha Vethantham; Amrita Chawla; Himanshu Vashistha; Moin A Saleem; Guohua Ding; Praveen N Chander; Ashwani Malhotra; Leonard G Meggs; Pravin C Singhal
Journal:  Am J Physiol Renal Physiol       Date:  2015-06-17

2.  Renin-Angiotensin-Aldosterone System Inhibition Increases Podocyte Derivation from Cells of Renin Lineage.

Authors:  Julia Lichtnekert; Natalya V Kaverina; Diana G Eng; Kenneth W Gross; J Nathan Kutz; Jeffrey W Pippin; Stuart J Shankland
Journal:  J Am Soc Nephrol       Date:  2016-04-14       Impact factor: 10.121

Review 3.  Wnt/β-catenin signalling and podocyte dysfunction in proteinuric kidney disease.

Authors:  Lili Zhou; Youhua Liu
Journal:  Nat Rev Nephrol       Date:  2015-06-09       Impact factor: 28.314

4.  Angiotensin II induces calcium/calcineurin signaling and podocyte injury by downregulating microRNA-30 family members.

Authors:  Yue Zhao; Junnan Wu; Mingchao Zhang; Minlin Zhou; Feng Xu; Xiaodong Zhu; Xianguang Zhou; Yue Lang; Fan Yang; Shifeng Yun; Shaolin Shi; Zhihong Liu
Journal:  J Mol Med (Berl)       Date:  2017-05-24       Impact factor: 4.599

5.  Deficiency of the Angiotensinase Aminopeptidase A Increases Susceptibility to Glomerular Injury.

Authors:  Juan Carlos Q Velez; Ehtesham Arif; Jessalyn Rodgers; Megan P Hicks; John M Arthur; Deepak Nihalani; Evelyn T Bruner; Milos N Budisavljevic; Carl Atkinson; Wayne R Fitzgibbon; Michael G Janech
Journal:  J Am Soc Nephrol       Date:  2017-02-15       Impact factor: 10.121

6.  Glucocorticoids in the treatment of patients with primary focal segmental glomerulosclerosis and moderate proteinuria.

Authors:  Jianni Huang; Li Lin; Jingyuan Xie; Xiao Li; Pingyan Shen; Xiaoxia Pan; Hong Ren; Nan Chen
Journal:  Clin Exp Nephrol       Date:  2018-05-14       Impact factor: 2.801

Review 7.  Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis.

Authors:  Vivette D D'Agati; Avry Chagnac; Aiko P J de Vries; Moshe Levi; Esteban Porrini; Michal Herman-Edelstein; Manuel Praga
Journal:  Nat Rev Nephrol       Date:  2016-06-06       Impact factor: 28.314

8.  DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS.

Authors:  Howard Trachtman; Peter Nelson; Sharon Adler; Kirk N Campbell; Abanti Chaudhuri; Vimal Kumar Derebail; Giovanni Gambaro; Loreto Gesualdo; Debbie S Gipson; Jonathan Hogan; Kenneth Lieberman; Brad Marder; Kevin Edward Meyers; Esmat Mustafa; Jai Radhakrishnan; Tarak Srivastava; Miganush Stepanians; Vladimír Tesar; Olga Zhdanova; Radko Komers
Journal:  J Am Soc Nephrol       Date:  2018-11       Impact factor: 10.121

9.  H(2)S inhibits hyperglycemia-induced intrarenal renin-angiotensin system activation via attenuation of reactive oxygen species generation.

Authors:  Hong Xue; Ping Yuan; Jun Ni; Chen Li; Decui Shao; Jia Liu; Yang Shen; Zhen Wang; Li Zhou; Wei Zhang; Yu Huang; Chen Yu; Rui Wang; Limin Lu
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

Review 10.  Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment.

Authors:  Nur Samsu
Journal:  Biomed Res Int       Date:  2021-07-08       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.